ERCC1 and osteosarcoma: A meta-analysis of six studies in 1137 patients with osteosarcoma suggested that in one Asian population (China), the ERCC1 rs11615 SNP is significantly associated with response to platinum-based chemotherapy, indicating that carriers of the C allele would benefit more from therapy [66].